Identifíquese
¿Aún no es suscriptor de la revista?
Comprar el acceso al artículo
Comprando el artículo el pdf del mismo podrá ser descargado
Teléfono para incidencias
De lunes a viernes de 9h a 18h (GMT+1) excepto los meses de julio y agosto que será de 9 a 15h
Llamadas desde España
932 415 960
Llamadas desde fuera de España
+34 932 415 960
Bibliograf¿a
[1]
Inflammatory Bowel Disease. N Engl J Med. 1996;334: 841-8.
[2]
Difficult differential diagnoses in IBD: ileitis and indeterminate colitis. Semin Gastrointest Dis. 2001;12:211-22.
[3]
Use of serologic tests in Crohn's disease. Clin Perspect Gastroenterol. 2001;4:155-64.
[4]
Colonoscopy during an attack of sever ulcerative colitis is a safe procedure and of a great value in clinical decision making. Am J Gastroenterol. 1991;86:187-90.
[5]
On making diagnosis of ulcerative colitis. Am J Gastroeneterol. 1997;92:1247-52.
[6]
The role of colonoscopy in the differential diagnosis of acute, severe, hemorrhagic colitis. Endoscopy. 1995;27:645-53.
[7]
Diagnostic utility of capsule endoscopy in non-confirmed Crohn's disease. Endoscopy. 2002;34 Suppl II:A70.
[8]
The biopsy in evaluating patients with inflammatory bowel disease. Med Clin North Am. 1980;64:1037-57.
[9]
Toxic megacolon: an annalysis of 70 cases. Dis Colon Rectum. 1986; 29:789.
[10]
Toxic megacolon. Lancet. 1998;351:509-13.
[11]
Extent of inflammatory lesions in ulcerative colitis assessed by radiology, colonoscopy and endoscopic biopsies. Gastrointest Radiol. 1979;4:394-400.
[12]
Pitfalls in the radiological diagnosis of inflammatory bowel disease. Can J Gastroenterol. 1990;4:317-23.
[13]
Imaging modalities in inflammatory bowel disease. Gastroenterol Clin North Am. 1999;28:391-421.
[14]
A prospective randomised comparison between small bowel enteroclysis ans small bowel follow-trough in Crohn's disease. Gastroenterology. 1997;113:390-8.
[15]
Radiologic and endoscopic diagnosis of Crohn's disease. Surg Clin North Am. 2001; 81:39-70.
[16]
Intestinal tuberculosis: return of an old disease. Am J Gastreonterol. 1998;93:692-6.
[17]
The irritable bowel syndrome. N Engl J Med. 2001;344:1846-50.
[18]
A review of collagenous colitis. Scand J Gastroenterol. 1998; 33:2-9.
[19]
The diagnostic yield of lower endoscopy plus biopsy in non-bloody diarrhea. Gastrointest Endosc. 1997;46:338-43.
[20]
Crohn's-like reaction in diverticular disease. Gut. 1998;42:392-5.
[21]
Cecal diverticulitis: a diagnostic challenge. Dig Surg. 2000;17:508-12.
[22]
Ileal carcinoid tumors stimulating Crohn's disease: incidence among 176 consecutive cases of ileal carcinoid. Am J Gastroenterol. 1997;92:2062-5.
[23]
Side effects of non-steroidal anti-inflammatory drugs on the small and large intestines in humans. Gastroenterology. 1993;104:1832-47.
[24]
Nonsteroidal anti-inflammatory drug-induced enteropathy: case discussion and a review of the literature. Mayo Clin Proc. 1995;70:55-61.
[25]
Therapy of inflammatory bowel disease. Gastroenterology. 2000;118 2 Suppl 1:S68-82.
[26]
Ulcerative colitis practice guidelines in adults. Am J Gastroenterol. 1997;92:204-11.
[27]
A meta-analysis and overview of the literature on treatment options for left-sided ulcerative colitis and ulcerative proctitis. Am J Gastroenterol. 2000;95:1263-76.
[28]
Combined therapy with 5-aminosalicylic acid tablets and enemas for maintaining remission in ulcerative colitis: a randomised double-blind study. Am J Gastroenterol. 1997;92:1143-7.
[29]
A comparison of mesalamine suspension enema and oral sulfasalazine for treatment of active distal ulcerative colitis in adults. Am J Gastroenterol. 1996;91:1338-42.
[30]
Progression of ulcerative proctosigmoiditis: incidence and risk factors influencing progression. Eur J Gastroenterol Hepatol. 1996;8:555.
[31]
Clinical patterns, natutal history and progression of ulcerative colitis. A long-term follow-up of 1116 patients. Dig Dis Sci. 1993;38:1137.
[32]
Course of ulcerative colitis: anaylisis of changes in disease activity over years. Gastroenterology. 1994;107:3.
[33]
The natural history of ulcerative proctitis: a multicenter, retrospective study. Am J Gastroenterol. 2000;95:469.
[34]
Rectal aminosalicylate therapy for distal ulcerative colitis: a meta-analysis. Alim Pharmacol Ther. 1995;293-300.
[35]
Dose-ranging study of masalamine (Pentasa) enemas of acute ulcerative proctosigmoiditis: results of a multicentered placebo-controlled trial. Inflamm Bowel Dis. 1998;4:79-83.
[36]
A double-blind comparison of oral versus rectal mesalamine versus combination therapy in the treatment of distal ulcerative coltis. Am J Gastroenterol. 1997;92:1867-71.
[37]
5-aminosalicylic acid enema in the treatment of distal ulcerative colitis, proctosigmoiditis and proctitis. Gastroenterology. 1987;92: 1894-8.
[38]
Intravenous cyclosporin in ulcerative colitis: a five-year experience. Am J Gastroenterol. 1999;94:1587-92.
[39]
Intravenous cyclosporine versus intravenous corticosteroids as single therapy for severe attacks of ulcerative colitis. Gastroenterology. 2001;120:1323-9.
[40]
Cyclosporin for severe ulcerative colitis: a user's guide. Am J Gastroenterol. 1997;92: 1424-8.
[41]
Cyclosporin in severe ulcerative colitis refractory to steroid therapy. N Engl J Med. 1994;330:1841-5.
[42]
Clinical Review: a critical review of cyclosporine therapy in inflammatory bowel disease. Inflamm Bowel Dis. 1995;1:48-63.
[43]
Effectiveness of cyclosporines A (CsA) in the treatment of active refractory ulcerative colitis (UC). Gastroenterology. 1998;114:A1096.
[44]
Infliximab for refractory ulcerative colitis. Am J Gastroenterol. 2001;96:2373-81.
[45]
Infliximab in the treatment of severe, steroid-refractory ulcerative colitis: a pilot study. Inflamm Bowel Dis. 2001;7:83-8.
[46]
Efficacy of anti-tumor necrosis factor therapy in patients with ulcerative colitis. Am J Gastroenterol. 2002;97:2577-84.
[47]
A controlled trial of azathioprine in the management of chronic ulcerative colitis. Gastroenterology. 1975;69:96-9.
[48]
The long-term outcome of ulcerative colitis treated with 6-mercaptopurine. Am J Gastroenterol. 1996;91:1711-4.
[49]
A controlled trial of azathioprine in chronic ulcerative colitis. Br Med J. 1982;284:1291-92.
[50]
Clinical course during the 1st year after diagnosis in ulcerative colitis and crohn's disease. Results of a large, prospective population-based study in southeastern Norway, 1990-1993. Scand J Gastroenterol. 1997;32:1005-12.
[51]
The role of azathioprine in the management of ulcerative colitis. Dis Colon Rectum. 1990;33:374-7.
[52]
A review of immune modifier therapy for inflammatory bowel disease: azathioprine, 6-mercaptopurines, cyclosporine and methotrexate. Am J Gastroenterol. 1996;91:423-33.
[53]
Development and validation of an endoscopic index of the severity for Crohn's disease: a prospective multicentre study. Groupe d'Études Thérapeutiques des Affections Inflammatoires du Tube Digestif (GETAID). Gut. 1989;30:983-9.
[54]
Management of Crohn's disease in adults. Am J Gastroenterol. 1997;92:559-66.
[55]
Medical therapy for crohn's disease: state of the art. Surg Clin North Am. 2001;81:71-101.
[56]
Double blind, placebo controlled trial of metronidazole in Crohn's disease. Gut. 1991;32:1071-5.
[57]
Long-term outcome of cirpofloxacin treatment in severe perianal or fistulous Crohn's disease. Gastroenterology. 1993;104:A793.
[58]
Oral budesonide for active Crohn's disease. Canadian Inflammatory Bowel Disease Study Group. N Engl J Med. 1994: 331:836-41.
[59]
A comparison of budesonide with prednisolone for active Crohn's disease. N Engl J Med. 1994;331:842-5.
[60]
A comparison of budesonide and mesalamine for active Crohn's disease. International Budesonide-mesalamine Study Group. N Engl J Med. 1998;339:370-4.
[61]
Integratin anti-tumor necrosis factor-alpha therapy in inflammatory bowel disease: current and future perspectives. Am J Gastroenterol. 2001;96:1977-97.
[62]
Evolving medical therapies for Crohn's disease. Curr Gastroenterol Rep. 2001;3:471-6.
[63]
Treatment of Crohn's Disease with mercaptopurine: a long-term, randomised, double-blind study. N Engl J Med. 1980;302:981-7.
[64]
Mesalamine in the maintenance treatment of Crohn's disease: a metaanalysis adjusting for confounding variables. Gastroenterology. 1997;113:1465-73.
[65]
Mesalamine in Crohn's disease with steroid induced remission: effect on steroid withdrawal and remission maintenance. Gastroenterology. 1996;110:688-93.
[66]
Azathioprine for maintaining remission in Crohn's disease. Cochrane Database Syst Rev. 2000;2:CD000067.
[67]
Oral budesonide as maintenance treatment for Crohn's disease: a placebo-controlled, dose-ranging study. Gastroenterology. 1996;110:45-51.
